We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

EU Approves Takeda's £46B Shire Deal With Drug Sale

Law360 (November 20, 2018, 3:46 PM EST) -- Europe’s competition watchdog on Tuesday greenlighted Japanese pharmaceutical giant Takeda’s £46 billion ($60 billion) buy of Dublin’s Shire, provided it sells Shire’s inflammatory bowel disease drug to a buyer that will...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.